Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03690427
Other study ID # 1R21HL145002-01
Secondary ID 1R21HL145002-01
Status Completed
Phase N/A
First received
Last updated
Start date December 11, 2018
Est. completion date September 27, 2021

Study information

Verified date July 2023
Source University of California, Los Angeles
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hookah (water-pipe) tobacco smoking has quickly grown to become a major global tobacco epidemic among youth; with electronic (e-) hookahs more recently increasing in popularity especially among young female adults, who endorse marketing claims that these products are a safer alternative to traditional hookah, but scientific evidence is lacking. The study aims to elucidate the comparative effects of traditional hookah smoking vs. e-hookah vaping on human vascular and endothelial function; and examine the role of inflammation and oxidative stress, as likely mechanisms in hookah-related cardiovascular disease pathogenesis.


Description:

Hookah (water-pipe) tobacco smoking is rapidly increasing in popularity worldwide. Contributing to this popularity is the unsubstantiated belief that traditional charcoal-heated hookah smoke is detoxified as it passes through the water-filled basin. More recently, electronic (e-) hookahs-containing flavored e-liquid that is heated electrically but inhaled through traditional water-pipes-are increasing in popularity in the United States among young female adults, who endorse marketing claims that these products are even safer than traditional charcoal-heated hookah products. The objective of this project is to investigate the comparative effects of traditional charcoal-heated hookah smoking versus e-hookah vaping on endothelial and vascular function and their mechanistic role in the development of cardiovascular disease. The investigators will test the hypothesis that: 1) in the absence of burning charcoal briquettes and virtually any carbon monoxide (CO) exposure, e-hookah vaping acutely impairs endothelial function and evokes acute central arterial stiffness, opposite from the endothelial function augmentation observed after traditional charcoal-heated hookah smoking, which is likely mediated by the large CO boost emitted from burning charcoal briquettes used to heat the flavored hookah tobacco; and 2) the processes of oxidative stress and inflammation play a pivotal mechanistic role underlying these vascular changes. Accordingly, in a cross-over study comparing traditional hookah smoking to e-hookah vaping, the investigators will assess endothelial function measured by brachial artery flow-mediated dilation and aortic stiffness by pulse wave velocity and augmentation index in 18 young healthy hookah smokers 21-39 years old, before and after ad lib 30-minute smoking/ vaping exposure sessions. To test for oxidative stress mediation, the investigators will determine if any acute impairment in endothelial function after e-hookah can be prevented by intravenous Vitamin C infusion, a potent anti-oxidant. Inflammatory and oxidant biomarkers, as well as smoking exposure biomarkers will be collected before and after the exposure sessions. The results of this proposal: (a) stand to fill in gaps in our mechanistic understanding of the comparative effect of traditional vs. e-hookah bowl on vascular and endothelial function; and (b) help inform policy decisions by the FDA about regulation of hookah products.


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date September 27, 2021
Est. primary completion date August 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 39 Years
Eligibility Inclusion Criteria: - 21-39 years old hookah smokers: smoked hookah >12x in last 12 months - no history of illicit drugs or marijuana - no evidence of cardiopulmonary disease by history/ physical - no diabetes: fasting blood glucose <100 mg/dl - BP<140/90mmHg - resting HR<100 bpm - BMI<30kg•m2 - no prescription medication Exclusion Criteria: - exhaled CO>10 ppm (smoking non-abstinence) - positive pregnancy test - psychiatric illness

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Traditional hookah smoking
Charcoal-heated hookah smoking
Electronic hookah vaping
Electronic hookah bowl inhalation

Locations

Country Name City State
United States University of California, Los Angeles Los Angeles California

Sponsors (3)

Lead Sponsor Collaborator
University of California, Los Angeles National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Flow-Mediated Dilation (FMD) Using ultrasound, FMD of the brachial artery induced by reactive hyperemia, was used to measure endothelium-dependent vasodilator function. Baseline diameter and velocity were recorded for 45 seconds and resumed 30 seconds before cuff deflation and continuously for 2 minutes after deflation to obtain true peak vasodilatory response. Pre- and post- the 30-minute smoking or vaping exposure sessions
Primary Carotid-Femoral Pulse Wave Velocity (Cf-PWV) Using applanation tonometry, cf-PWV was used to measure central arterial stiffness. Pre- and post- the 30-minute smoking or vaping exposure sessions
Primary HDL Oxidant Index (HOI) Capacity was determined as the ability of HDL to inhibit LDL-induced oxidation of dihydrodichlorofluorescein into the fluorescent dichlorofluorescein. Capacity was expressed as an HDL oxidative index, determined by the ratio of dichlorofluorescein fluorescence in the presence and absence of HDL. An index of < 1.0 denotes protective antioxidant HDL, whereas an index of > 1.0 indicates pro-oxidant HDL. Pre- and post- the 30-minute smoking or vaping exposure sessions
Primary Paraoxonase-1 (PON-1) Activity PON-1 activity was determined by the ability of PON-1, associated with HDL, to hydrolyze paraoxon substrate. The hydrolysis of paraoxon (diethyl-p-nitrophenyl phosphate) to p-nitrophenol by PON-1 was determined by incubating 5 mL of plasma with 1.0 mM paraoxon in 100 mM tris-HCl buffer (pH, 8.5).
Unit of Measure: expressed as micromoles of p-nitrophenol formed per minute for every 1 mL plasma.
Pre- and post- the 30-minute smoking or vaping exposure sessions
Primary Arylesterase Activity Arylesterase activity (lipid peroxidation biomarker) was determined by the rate of hydrolysis of phenyl acetate to phenol. Briefly, 4 mL plasma was incubated with 3.5 mM phenyl acetate in 9 mM Tris-HCl buffer (pH, 8.0) containing 0.9 mM CaCl2 at RT. The kinetics of phenol formation were determined by recording the absorbance at 270 nm every 15 s for 2 min.
Unit of Measure: nanomoles of product formed per minute per milliliter of plasma.
Pre- and post- the 30-minute smoking or vaping exposure sessions.
Primary High-sensitivity C-reactive Protein (Hs-CRP) Levels Plasma hs-CRP (inflammatory biomarker) Pre- and post- the 30-minute smoking or vaping exposure sessions
Primary Tumor Necrosis Factor-a (TNFa) Concentrations Plasma TNFa (inflammatory biomarker) Pre- and post- the 30-minute smoking or vaping exposure sessions
Secondary Flow-Mediated Dilation (FMD) Using ultrasound, FMD of the brachial artery, induced by reactive hyperemia, was used to measure endothelium-dependent vasodilator function after intravenous infusion of antioxidant ascorbic acid. Infusion of antioxidant ascorbic acid was done before the e-hookah vaping session. Effect of FMD with e-hookah vaping examined after pretreatment of intravenous infusion of antioxidant ascorbic acid (administered over 60 minutes at 0.5 mL min-1)
Secondary Endothelium-independent Vasodilator Function (Control Test for Endothelium-dependent Vasodilator Function) As a control test for the assessment of endothelium-dependent vasodilator function, using ultrasound the brachial artery, endothelium-independent dilatation was assessed by administering sublingual nitroglycerin. This measure was assessed 10 minutes after FMD testing. Ultrasound images were recorded continuously for a total of 10 minutes Pre- and post- sublingual administration of nitroglycerin (0.15 mg), which was administrated before and after e-hookah vaping.
Secondary Augmentation Index (AI) AI was used to measure central stiffness. It was calculated as the ratio of augmentation pressure (difference between the second and first systolic peaks of the aortic pressure waveform) and pulse pressure expressed as a percentage. Pre- and post- the 30-minute smoking or vaping exposure sessions
Secondary Interleukin 6 (IL-6) Levels Plasma IL-6 (inflammatory biomarker). A change between two points is reported below (e.g., value at post-exposure session minus value at pre-exposure session).
Secondary Interleukin 10 (IL-10) Levels Serum IL-10 (anti-inflammatory biomarker) A change between two points is reported below (e.g., value at post-exposure session minus value at pre-exposure session).
Secondary Nicotine Levels Plasma nicotine levels (smoking or vaping exposure biomarker) Pre- and post- the 30-minute smoking or vaping exposure sessions
Secondary Carbon Monoxide (CO) Levels Exhaled CO levels (smoking or vaping exposure biomarker) Pre- and post- the 30-minute smoking or vaping exposure sessions
See also
  Status Clinical Trial Phase
Completed NCT03995979 - Inflammation and Protein Restriction N/A
Completed NCT03255187 - Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT03577223 - Egg Effects on the Immunomodulatory Properties of HDL N/A
Completed NCT04383561 - Relationship Between LRG and Periodontal Disease N/A
Active, not recruiting NCT03622632 - Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
Completed NCT06216015 - Exercise Training and Kidney Transplantation N/A
Completed NCT04856748 - Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
Completed NCT05529693 - Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population N/A
Recruiting NCT05670301 - Flemish Joint Effort for Biomarker pRofiling in Inflammatory Systemic Diseases N/A
Recruiting NCT05415397 - Treating Immuno-metabolic Depression With Anti-inflammatory Drugs Phase 3
Recruiting NCT05775731 - Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
Recruiting NCT04543877 - WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study Early Phase 1
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Completed NCT03429920 - Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors N/A
Completed NCT06065241 - Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals. N/A
Completed NCT05864352 - The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
Completed NCT03318731 - Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males N/A
Not yet recruiting NCT06134076 - Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota N/A
Not yet recruiting NCT05910489 - Micro and Nanoplastics in Greenhouse Workers: Biomarkers of Exposure and Effect